摘要
由一名新闻记者-机器人与机器学习的工作人员新闻编辑每日新闻-关于血肿的新研究是一份报告的主旨。根据NewsRx编辑在南京的新闻报道，研究表明：“自发性脑出血(ICH)占中风总数的20%，30天内死亡率为40%。尽管保守治疗仍是小血肿脑出血患者的常规治疗方法，但仍有较高的死亡率。”"术后残留血肿15毫升的患者,其功能预后和生存率均较好."本文报道了机器人立体定向辅助(ROSA)作为一种安全有效的STE RETIC抽吸术和血栓内导管置入方法的临床经验，对接受ROSA引导下ICH抽吸术的自发性脑出血患者进行回顾性分析，ROSA引导下ICH抽吸术。本研究采用ROSA One脑抽吸ICH，制定抽吸INT导管放置方案，制定具体的手术流程（术前、术中、术后处理），并提供相应的随访护理，2021年9月14日至2022年5月4日共收治7例ICH患者，根据工作流程设计，ROSA引导下立体定向ICH抽吸术能有效地抽吸血肿体积的50%以上(大面积血肿>30ml),使血肿残留减少至15ml以下,平均手术时间1.3±0.3h,术中出血量少,无并发症发生,无需置管,术后功能状态改善。
Abstract
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Hematoma is the subjec t of a report. According to news reporting out of Nanjing, People's Republic of China, by NewsRx editors, research stated, "Spontaneous intracerebral hemorrhage (ICH) accounts for up to 20% of all strokes and results in 40% mortality at 30 days. Although conservative medical management is still the stan dard treatment for ICH patients with small hematoma, patients with residual hema toma 15 mL after surgery are associated with better functional outcomes and surv ival rates." Our news journalists obtained a quote from the research from the Nanjing Univers ity of Chinese Medicine, "This study reported our clinical experience with using Robotic Stereotactic Assistance (ROSA) as a safe and effective approach for ste reotactic ICH aspiration and intra-clot catheter placement. A retrospective anal ysis was conducted of patients with spontaneous ICH who underwent ROSA-guided IC H aspiration surgery. ROSA-guided ICH surgical techniques, an aspiration and int ra-clot catheter placement protocol, and a specific operative workflow (pre-oper ative protocol, intraoperative procedure and postoperative management) were empl oyed to aspirate ICH using the ROSA One Brain, and appropriate follow-up care wa s provided. From September 14, 2021 to May 4, 2022, a total of 7 patients were i ncluded in the study. Based on our workflow design, ROSA-guided stereotactic ICH aspiration effectively aspirated more than 50% of hematoma volume (or more than 30 mL for massive hematomas), thereby reducing the residual hemat oma to less than 15 mL. The mean operative time of entire surgical procedure was 1.3 ± 0.3 h, with very little perioperative blood loss and no perioperative com plications. No patients required catheter replacement and all patients' function al status improved."
NETL
NSTL